VeriMomeugenyl phenylacetate hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction found for eugenyl phenylacetate; no peer‑reviewed reproductive or developmental toxicity data located (PubMed/CosIng/PubChem searches). As a fragrance ester of eugenol, theoretical metabolic hydrolysis to eugenol is possible, but eugenol itself does not carry harmonised reproductive hazard; topical cosmetic exposure is expected to give low but measurable systemic exposure (dermal absorption plausible for small lipophilic esters). Sources: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no relevant repro studies), CIR (no specific assessment for this ester).
Related ingredients
Frequently asked questions
- eugenyl phenylacetate hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction found for eugenyl phenylacetate; no peer‑reviewed reproductive or developmental toxicity data located (PubMed/CosIng/PubChem searches). As a fragrance ester of eugenol, theoretical metabolic hydrolysis to eugenol is possible, but eugenol itself does not carry harmonised reproductive hazard; topical cosmetic exposure is expected to give low but measurable systemic exposure (dermal absorption plausible for small lipophilic esters). Sources: ECHA C&L (no harmonised classification), PubChem, CosIng, PubMed (no relevant repro studies), CIR (no specific assessment for this ester).
- eugenyl phenylacetate emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific hazard or harmonised classification. Systemic transfer into milk cannot be excluded for low‑molecular lipophilic esters but there are no data demonstrating significant milk transfer for this ingredient; exposure from normal topical cosmetic use is expected to be low. Sources: ECHA C&L, PubChem, CosIng, PubMed.
- eugenyl phenylacetate bebek cildi için güvenli mi?
- No infant‑specific toxicity or developmental data found. Because infant skin has higher absorption (immature barrier and higher surface area:weight) and this is a small lipophilic ester that may be dermally absorbed, exposure for a baby (0–3 yr) is increased relative to adults; however no evidence indicates reproductive or developmental hazard specific to the compound. Sources: CosIng, PubChem, general pediatric dermal absorption principles and lack of specific toxicity data in PubMed/ECHA.
- VeriMom eugenyl phenylacetate nasıl puanlıyor?
- VeriMom eugenyl phenylacetate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte eugenyl phenylacetate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.